122 related articles for article (PubMed ID: 1712977)
1. High-dose-rate intraluminal brachytherapy for bile duct carcinoma after surgery.
Kurisu K; Hishikawa Y; Taniguchi M; Kamikonya N; Miura T; Kanno H; Okamoto E
Radiother Oncol; 1991 May; 21(1):65-6. PubMed ID: 1712977
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy of postoperative residual tumor of bile duct carcinoma.
Kurisu K; Hishikawa Y; Miura T; Kanno H; Okamoto E
Radiat Med; 1991; 9(2):82-4. PubMed ID: 1658858
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate intraluminal brachytherapy for postoperative residual tumor of gallbladder carcinoma: a case report.
Kurisu K; Hishikawa Y; Taniguchi M; Kamikonya N; Miura T; Kanno H; Okamoto E
Radiat Med; 1991; 9(6):241-3. PubMed ID: 1823398
[TBL] [Abstract][Full Text] [Related]
4. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas.
Fritz P; Brambs HJ; Schraube P; Freund U; Berns C; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):855-61. PubMed ID: 8040034
[TBL] [Abstract][Full Text] [Related]
5. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy.
Kamada T; Saitou H; Takamura A; Nojima T; Okushiba SI
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):767-74. PubMed ID: 8598352
[TBL] [Abstract][Full Text] [Related]
6. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.
Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J
Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240
[TBL] [Abstract][Full Text] [Related]
7. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
Schleicher UM; Staatz G; Alzen G; Andreopoulos D
Strahlenther Onkol; 2002 Dec; 178(12):682-7. PubMed ID: 12491056
[TBL] [Abstract][Full Text] [Related]
8. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.
Takamura A; Saito H; Kamada T; Hiramatsu K; Takeuchi S; Hasegawa M; Miyamoto N
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1357-65. PubMed ID: 14630274
[TBL] [Abstract][Full Text] [Related]
9. [A case of intraluminal/external irradiation, chemotherapy and T-tube stent treatment for the local recurrence of the postoperative four-year bile duct cancer].
Yoshitomi M; Horiuchi H; Kawahara R; Uchida S; Hisaka T; Sakai T; Maruyama Y; Kinoshita H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2129-31. PubMed ID: 19106546
[TBL] [Abstract][Full Text] [Related]
10. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.
Shin HS; Seong J; Kim WC; Lee HS; Moon SR; Lee IJ; Lee KK; Park KR; Suh CO; Kim GE
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):105-12. PubMed ID: 12909222
[TBL] [Abstract][Full Text] [Related]
11. Biliary tree malignancies.
Erickson BA; Nag S
J Surg Oncol; 1998 Mar; 67(3):203-10. PubMed ID: 9530894
[TBL] [Abstract][Full Text] [Related]
12. [Improved treatment results in advanced gallbladder and bile duct cancer by postoperative combined radiotherapy].
Jörling P; Schmid HU; Leber K; Haubold B; Junghanns K
Leber Magen Darm; 1992 May; 22(3):116-9. PubMed ID: 1625509
[TBL] [Abstract][Full Text] [Related]
13. Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region.
Dvorák J; Petera J; Papík Z; Melichar B; Vanásek T; Hulek P; Jandík P; Mergancová J; Zoul Z; Vacek Z
Hepatogastroenterology; 2002; 49(46):1045-7. PubMed ID: 12143198
[TBL] [Abstract][Full Text] [Related]
14. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer.
Alden ME; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):945-51. PubMed ID: 8138448
[TBL] [Abstract][Full Text] [Related]
15. Combined modality treatment in unresectable extrahepatic biliary carcinoma.
Morganti AG; Trodella L; Valentini V; Montemaggi P; Costamagna G; Smaniotto D; Luzi S; Ziccarelli P; Macchia G; Perri V; Mutignani M; Cellini N
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):913-9. PubMed ID: 10705013
[TBL] [Abstract][Full Text] [Related]
16. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma.
González González D; Gouma DJ; Rauws EA; van Gulik TM; Bosma A; Koedooder C
Ann Oncol; 1999; 10 Suppl 4():215-20. PubMed ID: 10436826
[TBL] [Abstract][Full Text] [Related]
17. Role of intraluminal brachytherapy as a palliative treatment modality in unresectable cholangiocarcinomas.
Chigurupalli K; Vashistha A
J Cancer Res Ther; 2021; 17(1):10-12. PubMed ID: 33723125
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic biliary duct carcinoma: the continuing evolution of multidisciplinary management.
Regine WF; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):963-4. PubMed ID: 8598377
[No Abstract] [Full Text] [Related]
19. Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheter.
Deufel CL; Furutani KM; Dahl RA; Grams MP; McLemore LB; Hallemeier CL; Neben-Wittich M; Martenson JA; Haddock MG
Brachytherapy; 2018; 17(4):718-725. PubMed ID: 29776892
[TBL] [Abstract][Full Text] [Related]
20. The role of radiotherapy in the treatment of bile duct carcinoma.
Veeze-Kuijpers B; Meerwaldt JH; Lameris JS; van Blankenstein M; van Putten WL; Terpstra OT
Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):63-7. PubMed ID: 2153649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
